Deterred by misperceptions, lack of information, logistics hurdles or cost concerns, less than five percent of cancer patients today join clinical trials in the U.S. denying potential health improvements to them and scientific insights to researchers.
Our modern societies, all strongly based on technological improvements, consistently demand a solid scientific and technological knowledge from those who wish to be considered citizens.